North America Clinical Trials Market Size, Share & Trends Report

North America Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Service Type, By Sponsor, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-202-2
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

North America Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
North America Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)
- Interventional
- Observational
- Expanded Access
North America Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Autoimmune/Inflammation
  - Interventional
  - Observational
  - Expanded Access
- Pain Management
  - Interventional
  - Observational
  - Expanded Access
- Oncology
  - Interventional
  - Observational
  - Expanded Access
- CNS Conditions
  - Interventional
  - Observational
  - Expanded Access
- Diabetes
  - Interventional
  - Observational
  - Expanded Access
- Obesity
  - Interventional
  - Observational
  - Expanded Access
- Cardiovascular
  - Interventional
  - Observational
  - Expanded Access
- Others
  - Interventional
  - Observational
  - Expanded Access
North America Clinical Trials Indication By Study Design Outlook (Revenue, USD Million, 2018 - 2030)
- Autoimmune/Inflammation
  - Rheumatoid Arthritis
  - Multiple Sclerosis
  - Osteoarthritis
  - Irritable Bowel Syndrome (IBS)
  - Others
- Pain Management
  - Chronic Pain
  - Acute Pain
- Oncology
  - Blood Cancer
  - Solid Tumors
  - Others
- CNS Conditions
  - Epilepsy
  - Parkinson's Disease (PD)
  - Huntington's Disease
  - Stroke
  - Traumatic Brain Injury (TBI)
  - Amyotrophic Lateral Sclerosis (ALS)
  - Muscle Regeneration
  - Others
- Diabetes
- Obesity
- Cardiovascular
- Others
North America Clinical Trials Sponsor Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Others
North America Clinical Trials Service Type Outlook (Revenue, USD Million, 2018 - 2030)
- Regulatory Affairs
- Site Identification, Selection and Management
- Drug Logistics
- Laboratory Services
- Patient Recruitment and Retention
- Data Management
- Others
North America Clinical Trials Regional Outlook (Revenue, USD Million, 2018 - 2030)
- U.S.
  - U.S. Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - U.S. Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)
    - Interventional
    - Observational
    - Expanded Access
  - U.S. Clinical Trials Indication By Study Design Outlook (Revenue, USD Million, 2018 - 2030)
    - Autoimmune/Inflammation
      - Rheumatoid Arthritis
      - Multiple Sclerosis
      - Osteoarthritis
      - Irritable Bowel Syndrome (IBS)
      - Others
    - Pain Management
      - Chronic Pain
      - Acute Pain
    - Oncology
      - Blood Cancer
      - Solid Tumors
      - Others
    - CNS Conditions
      - Epilepsy
      - Parkinson's Disease (PD)
      - Huntington's Disease
      - Stroke
      - Traumatic Brain Injury (TBI)
      - Amyotrophic Lateral Sclerosis (ALS)
      - Muscle Regeneration
      - Others
    - Diabetes
    - Obesity
    - Cardiovascular
    - Others
  - U.S. Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Autoimmune/Inflammation
      - Interventional
      - Observational
      - Expanded Access
    - Pain Management
      - Interventional
      - Observational
      - Expanded Access
    - Oncology
      - Interventional
      - Observational
      - Expanded Access
    - CNS Conditions
      - Interventional
      - Observational
      - Expanded Access
    - Diabetes
      - Interventional
      - Observational
      - Expanded Access
    - Obesity
      - Interventional
      - Observational
      - Expanded Access
    - Cardiovascular
      - Interventional
      - Observational
      - Expanded Access
    - Others
      - Interventional
      - Observational
      - Expanded Access
  - U.S. Clinical Trials Sponsor Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical & Biopharmaceutical Companies
    - Medical Device Companies
    - Others
  - U.S. Clinical Trials Service Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Regulatory Affairs
    - Site Identification, Selection and Management
    - Drug Logistics
    - Laboratory Services
    - Patient Recruitment and Retention
    - Data Management
    - Others
  - U.S. Clinical Trials Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
    - In-house
    - Outsourcing
- Canada
  - Canada Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
    - Phase I
    - Phase II
    - Phase III
    - Phase IV
  - Canada Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)
    - Interventional
    - Observational
    - Expanded Access
  - Canada Clinical Trials Indication By Study Design Outlook (Revenue, USD Million, 2018 - 2030)
    - Autoimmune/Inflammation
      - Rheumatoid Arthritis
      - Multiple Sclerosis
      - Osteoarthritis
      - Irritable Bowel Syndrome (IBS)
      - Others
    - Pain Management
      - Chronic Pain
      - Acute Pain
    - Oncology
      - Blood Cancer
      - Solid Tumors
      - Others
    - CNS Conditions
      - Epilepsy
      - Parkinson's Disease (PD)
      - Huntington's Disease
      - Stroke
      - Traumatic Brain Injury (TBI)
      - Amyotrophic Lateral Sclerosis (ALS)
      - Muscle Regeneration
      - Others
    - Diabetes
    - Obesity
    - Cardiovascular
    - Others
  - Canada Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)
    - Autoimmune/Inflammation
      - Interventional
      - Observational
      - Expanded Access
    - Pain Management
      - Interventional
      - Observational
      - Expanded Access
    - Oncology
      - Interventional
      - Observational
      - Expanded Access
    - CNS Conditions
      - Interventional
      - Observational
      - Expanded Access
    - Diabetes
      - Interventional
      - Observational
      - Expanded Access
    - Obesity
      - Interventional
      - Observational
      - Expanded Access
    - Cardiovascular
      - Interventional
      - Observational
      - Expanded Access
    - Others
      - Interventional
      - Observational
      - Expanded Access
  - Canada Clinical Trials Sponsor Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical & Biopharmaceutical Companies
    - Medical Device Companies
    - Others
  - Canada Clinical Trials Service Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Regulatory Affairs
    - Site Identification, Selection and Management
    - Drug Logistics
    - Laboratory Services
    - Patient Recruitment and Retention
    - Data Management
    - Others
  - Canada Clinical Trials Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
    - In-house
    - Outsourcing

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.